Apix 2.5 mg (Apixaban 2.5 mg, Unipharm, 60 Coated Tablets) is a modern direct oral anticoagulant (direct factor Xa inhibitor) manufactured by Unipharm. By selectively blocking Factor Xa, Apix prevents thrombin generation and blood clot formation, significantly reducing the risk of stroke, systemic embolism, and deep vein thrombosis.

Indicações: Apix 2.5 mg is indicated for:

• Prevention of venous thromboembolism (VTE) in adult patients following elective hip or knee replacement surgery

• Prevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation (NVAF)

• Treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE)

• Prevention of recurrent DVT and PE

Razões para o uso:

• Diagnosed non-valvular atrial fibrillation with elevated thromboembolic risk

• Post-operative recovery following major orthopedic joint surgeries

• Predisposition to blood clot formation in the venous system

• Medical recommendation for long-term anticoagulant protection

Principais recursos:

• Active ingredient — Apixaban 2.5 mg

• Direct and selective Factor Xa inhibitor

• Does not require routine international normalized ratio (INR) monitoring

• Film-coated tablet form for convenient daily administration

• Standard pack containing 60 coated tablets

Forma de dosagem: Apix 2.5 — Coated tablets, 2.5 mg (pack of 60 tablets)

Fabricante: Unipharm

Ingredientes ativos:

• Apixaban — 2.5 mg

#Apix #Apixaban #Apix25 #Unipharm #Anticoagulant #BloodThinner #StrokePrevention #ThrombosisPrevention #IsraeliPharmacy #MedsFromIsrael